Metal-free, visible-light photoredox catalysis: transformation of arylmethyl bromides to alcohols and aldehydes

Jian Liab, Hongni Wangab, Li Liuc and Jiangtao Sun*ab
aSchool of Pharmaceutical Engineering & Life Sciences, Changzhou University, Changzhou, 213164, P.R. China
bKey Laboratory of Advanced Catalytic Materials and Technology, Changzhou University, Changzhou, 213164, P.R. China. E-mail: jtsun08@gmail.com
cSchool of Petrochemical Engineering, Changzhou University, Changzhou, 213164, P.R. China

Received 24th August 2014 , Accepted 16th September 2014

First published on 16th September 2014


Abstract

A mild, simple, and controllable metal-free photocatalytic system for the transformation of arylmethyl bromides to corresponding alcohols and aldehydes in high yields with visible-light irradiation has been achieved. Eosin Y was found to be an efficient promoter for this oxidative dehalogenation reaction under photo irradiation conditions.


Benzyl halides are versatile intermediates in organic synthesis1 and they can be utilized as starting materials in the preparation of alcohols and aldehydes.2 Although there are many methods that have been developed for the transformation of arylmethyl halides to the corresponding alcohols and the oxidation of arylmethyl alcohols to the corresponding aldehydes, some fatal problems such as drastic conditions or environmentally detrimental heavy metals still remain.3 As a result, considerable effort has been directed towards the development of mild and efficient methods for preparation of benzyl alcohols and corresponding aldehydes from benzyl halides.

Sunlight is an important, abundant, clean, and renewable energy source. Visible light accounts for 43% of the incoming solar radiation, and therefore many chemical transformations have been developed with visible light to meet the challenge of environmental sustainability.4 Many visible-light photoredox catalysts such as ruthenium or iridium polypyridyl complexes have been used to solve the problem of visible light absorption efficiency.5 The groups of Yoon,6 MacMillan,7 Stephenson8 and others9 have demonstrated the ability of photoredox catalysts such as Ru(bpy)3Cl2, and [Ir(bpy)2(dtbbpy)]PF6. Notably, such photocatalysts were utilized to functionalize C–H bonds and reduce activated C–Br bonds to afford intra- and intermolecular radical reactions. Recently, Jiao described a Ru(bpy)3Cl2 and pyridine-cocatalyzed utilization of sunlight and air in the aerobic oxidation of benzyl halides to corresponding carbonyl compounds10 (Scheme 1). However, photoredox metal-catalysts are toxic and expensive. In 2001, Itoh's group developed an oxidative transformation of arylmethyl bromides to corresponding alcohols and aldehydes with a combination of alkali iodides under photoirradiation conditions11 (Scheme 1).


image file: c4ra09190f-s1.tif
Scheme 1 Transformation of arylmethyl bromides to alcohols and aldehydes.

On the other hand, because of their inexpensive and environmentally friendly nature, organic dyes, such as Eosin Y, would be an appropriate alternative to metal photocatalysts.12 To explore the application of photocatalysts and to overcome the drawbacks of the above-mentioned transformation methods, herein we report the controllable transformation of benzylic bromides to the corresponding alcohols and benzaldehydes using Eosin Y as a photocatalyst with visible-light irradiation under mild conditions (Scheme 1).

We initiated our investigations using 3-nitrobenzyl bromide (1a) as the model substrate. We tested various reaction conditions for the transformation of 3-nitrobenzyl bromide to the corresponding alcohol and aldehyde (Table 1). First, 3-nitrobenzyl bromide was dissolved in DMSO without catalyst at room temperature for 12 hours under fluorescent bulb irradiation and no products 2a or 3a were obtained (entry 1, Table 1). Then 5 mol% of Eosin Y was employed; the reaction occurred to afford 2a in 92% yield in 12 hours (entry 2, Table 1). The reaction did not proceed at all without the radiation of visible light (entry 3, Table 1). Next we carried out the reaction under Ar atmosphere and only 5% yield of 2a was found, meaning that O2 is essential for the reaction process. Further studies were thus carried out regarding the influence of different solvents, such as H2O, DMF, DMA, NMP, and CH3CN. It is interesting that 4% to 0% yields were detected with GC-MS (entries 5–10, Table 1). Moreover, when prolonging the reaction time, the yield of 3-nitrobenzyl aldehyde was promoted. Gratifyingly, the yield of the corresponding aldehyde increased to 85% after 12 hours when the temperature was increased from 25 °C to 80 °C (entry 14, Table 1).

Table 1 Optimization of the model reactiona

image file: c4ra09190f-u1.tif

Entry Catalyst T (°C) Solvent Yieldb (%) 2a/3a
a 3-Nitrobenzyl bromide 1a (0.5 mmol) in solvent (1 mL) was mixed with 5 mol% of catalyst at r.t. for 12 hours.b GC yields.c Proceeded without visible light.d Proceeded under Ar atmosphere.e Stirred for 24 hours.f Stirred for 48 hours.
1 25 DMSO
2 Eosin Y 25 DMSO 92/6
3c Eosin Y 25 DMSO
4d Eosin Y 25 DMSO 5/0
5 Eosin Y 25 H2O 2/0
6 Eosin Y 25 DMF
7 Eosin Y 25 DMA
8 Eosin Y 25 NMP Trace/—
9 Eosin Y 25 CH3CN 4/0
10 Eosin Y 25 DME
11e Eosin Y 25 DMSO 81/15
12f Eosin Y 25 DMSO 78/20
13 Eosin Y 40 DMSO 12/56
14 Eosin Y 80 DMSO 11/85


It is noteworthy that (chloromethyl)benzene could not transform into the desired product. When (chloromethyl)benzene was utilized under standard conditions, no desired product 2b was observed (Scheme 2).


image file: c4ra09190f-s2.tif
Scheme 2 Transformation of (chloromethyl)benzene to alcohols.

After screening of various catalysts, reaction temperatures and solvents, it can be concluded that the optimized reaction conditions are as follows: benzylic bromides in DMSO is reacted under fluorescent bulb irradiation with 5 mol% Eosin Y at 25 °C for preparation of benzalcohols and higher temperature for benzaldehydes.

With the optimized reaction conditions in hand, we probed the scope of benzylic bromides. The results are summarized in Table 2. The reaction scope was subsequently explored by using various benzylic bromides; the substrates bearing an electron-withdrawing group on benzene ring 1e–1f resulted in better yields than those bearing an electron-donating group 1h–1i. Likewise, meta-substituted substrates posed no problem in this reaction, as exemplified by m-fluorine product 2l and m-nitro product 2a. Steric bulk in the ortho-position was very well tolerated, as demonstrated by the substrates 1m–1p to yield highly congested products 2m–2p. Furthermore, all of the above reactions smoothly proceeded to give benzaldehydes 3 in moderate yields at 80 °C in 12 hours.

Table 2 Transformation of arylmethyl bromides to alcohols and aldehydesa,b,c

image file: c4ra09190f-u2.tif

a Standard conditions: arylmethyl bromides (1) (0.5 mmol) in DMSO (1 mL) were mixed with 5 mol% of Eosin Y at r.t. for 12 hours to give alcohols (2); the mixture was stirred at 80 °C overnight to give aldehydes (3).b Isolated yields.c Representative procedure: under air atmosphere, arylmethyl bromides (1) (0.5 mmol) in DMSO (1 mL) were mixed with 5 mol% of Eosin Y under 24 W fluorescent bulb irradiation at r.t./80 °C for 12/24 hours, H2O (2 mL) and CH2Cl2 (5 mL) were added to the reaction mixture separately, the water phase was extracted with CH2Cl2 (5 mL × 3), the organic layer was combined and concentrated, and the residue was purified by column chromatography (SiO2, petroleum ether–ethyl acetate = 10[thin space (1/6-em)]:[thin space (1/6-em)]1–4[thin space (1/6-em)]:[thin space (1/6-em)]1) to give the corresponding alcohols or aldehydes.
image file: c4ra09190f-u3.tif


Encouraged by the results above, we then extended the substrate to heterocyclic and fused rings using the Eosin Y-catalyzed system shown in Table 3.

Table 3 Transformation of arylmethyl bromides to alcohols and aldehydesa,b

image file: c4ra09190f-u4.tif

a Standard conditions.b Isolated yields.
image file: c4ra09190f-u5.tif


It can be seen that the heterocyclic substituted benzylic bromides proved to be viable starting materials; some afforded lower yields, such as 2-furan bromide 1q, whilst 2-thiopheneyl bromide 1r and 1s afforded the desired products in moderate yields (2q–2s and 3q–3s, Table 3). The fused ring substrates also worked well and afforded products 2t and 2u in 80% and 89% yields, respectively.

Subsequently, we explored the scope of benzylic bromides under optimized reaction conditions, with substituted (1-bromoethyl)benzene employed as substrates. As shown in Table 4, both electron-rich and electron-deficient groups at different position (para-, meta-, and ortho-position) of (1-bromoethyl)benzenes could be smoothly transformed into the desired products with good yields. A wide range of different groups at the aromatic moiety of (1-bromoethyl)benzenes, such as halogen, trifluoromethyl, nitro and amine, generated the corresponding 1-phenylethanol products 4 in 63–87% yields (Table 4), even for the slightly more complex substrate 4i.

Table 4 Transformation of (1-bromoethyl)benzene aryls to alcoholsa,b

image file: c4ra09190f-u6.tif

a Standard conditions.b Isolated yields.
image file: c4ra09190f-u7.tif


It was interesting that when (1-bromoethyl)benzene was used, the corresponding product 1-phenylethanol (4a) was obtained in 84% yield at room temperature after 12 hours, but if the mixture continued to stir for another 12 hours at 80 °C, 2,2-dihydroxy-1-phenylethanone 5 was collected in 80% yield (Scheme 3).


image file: c4ra09190f-s3.tif
Scheme 3 Photoredox catalysis of (1-bromoethyl)benzene.

This photocatalyst transformation could serve as a new method for the synthesis of important intermediates for pharmaceutical as well as natural products. Rosuvastatin, a synthetic inhibitor of HMG-CoA reductase which plays a major role in second generation drugs,13 was chosen as the target compound.14 The benzyl bromide intermediate (6)15 was treated under standard conditions, and 82% yield of benzyl alcohol 7 and 31% yield of benzyl aldehyde (8) were obtained accordingly (Scheme 4).


image file: c4ra09190f-s4.tif
Scheme 4 Synthesis of rosuvastatin using the photocatalyst strategy.

In conclusion, a simple and efficient transformation of arylmethyl bromides to the corresponding alcohols and the oxidation of arylmethyl alcohols to the corresponding aldehydes has been developed with Eosin Y as the photocatalyst in DMSO. Various benzylic bromides and (1-bromoethyl)benzene (1) could perform the reaction under mild reaction conditions, producing alcohols and aldehydes in up to 91% yields. This method could be used in the syntheses of intermediates for pharmaceutical and natural products. Further investigations on the mechanism are currently underway in our lab.

Acknowledgements

We are grateful to the National Natural Science Foundation of China (21402013), the Natural Science Foundation of Jiangsu (BK20140259), the Priority Academic Program Development of Jiangsu Higher Education Institutions and Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology for generous financial support for our research.

Notes and references

  1. (a) A. Kamal and G. Chouhan, Tetrahedron Lett., 2005, 46, 1489 CrossRef CAS PubMed; (b) H. Sharghi, R. Khalifeh and M. M. Doroodmand, Adv. Synth. Catal., 2009, 351, 207 CrossRef CAS; (c) G. Laven, M. Kalek and M. Jezowska, New J. Chem., 2010, 34, 967 RSC; (d) M. Murata, Heterocycles, 2012, 85, 1795 CrossRef CAS PubMed; (e) S. Sumino, A. Fusano, T. Fukuyama and I. Ryu, Acc. Chem. Res., 2014, 47, 1563 CrossRef CAS PubMed.
  2. (a) Q. Liu, M. Lu, F. Sun, J. Li and Y. Zhao, Synth. Commun., 2008, 38, 4188 CrossRef CAS; (b) W. K. Siddheshwar, R. P. Nitin and D. S. Shriniwas, Tetrahedron Lett., 2008, 49, 1160 CrossRef PubMed; (c) F. Heidarizadeh and H. Asareh, Asian J. Chem., 2009, 21, 949 CAS; (d) S. W. Kshirsagar, N. R. Patil and S. D. Samant, Res. J. Pharm., Biol. Chem. Sci., 2010, 1, 48 CAS; (e) K. Kulangiappar, M. Anbu Kulandainathan and T. Raju, Ind. Eng. Chem. Res., 2010, 49, 6670 CrossRef CAS; (f) K. Bannarak, P. Wong and P. Mookda, Tetrahedron Lett., 2013, 54, 1983 CrossRef PubMed.
  3. Comprehensive Organic Transformations: A Guide to Functional Group Preparations, R. C. Larock, ed. Wiley-VCH, New York, 1989 Search PubMed.
  4. For latest reviews on photoredox catalysis, see: (a) J. W. Tucker and C. R. J. Stephenson, J. Org. Chem., 2012, 77, 1617 CrossRef CAS PubMed; (b) J. Xuan and W.-J. Xiao, Angew. Chem., Int. Ed., 2012, 51, 6828 CrossRef CAS PubMed; (c) T. Koike and M. Akita, Synlett, 2013, 24, 2492 CrossRef CAS PubMed; (d) D. Ravelli, S. Protti, M. Fagnoni and A. Albini, Curr. Org. Chem., 2013, 17, 2366 CrossRef CAS; (e) M. Reckenthaeler and A. G. Griesbeck, Adv. Synth. Catal., 2013, 355, 2727 CrossRef CAS; (f) Y.-Q. Zou, J.-R. Chen and W.-J. Xiao, Angew. Chem., Int. Ed., 2013, 52, 11701 CrossRef CAS PubMed; (g) Y. Xi, H. Yi and A. Lei, Org. Biomol. Chem., 2013, 11, 2387 RSC; (h) C. K. Prier, D. A. Rankic and D. W. C. MacMillan, Chem. Rev., 2013, 113, 5322 CrossRef CAS PubMed; (i) M. N. Hopkinson, B. Sahoo, J.-L. Li and F. Glorius, Chem.–Eur. J., 2014, 20, 3874 CrossRef CAS PubMed.
  5. For recent selected examples for visible-light photoredox catalysts such as ruthenium or iridium complexes, see: (a) K. Zeitler, Angew. Chem., 2009, 121, 9969 (Angew. Chem., Int. Ed., 2009, 48, 9785) CrossRef; (b) J. Du and T. P. Yoon, J. Am. Chem. Soc., 2009, 131, 14604 CrossRef CAS PubMed; (c) D. Ravelli, D. Dondi, M. Fagnoni and A. Albini, Chem. Soc. Rev., 2009, 38, 1999 RSC; (d) A. G. Condie, J. C. González-Gómez and C. R. J. Stephenson, J. Am. Chem. Soc., 2010, 132, 1464 CrossRef CAS PubMed; (e) Y. Q. Zou, J. R. Chen, X. P. Liu, L. Q. Lu, R. L. Davis, K. A. Joergensen and W. J. Xiao, Angew. Chem., Int. Ed., 2012, 51, 784 CrossRef CAS PubMed; (f) H. Kim and C. Lee, Angew. Chem., Int. Ed., 2012, 51, 12303 CrossRef CAS PubMed; (g) S. Sato, T. Morikawa, T. Kajino and O. Ishitani, Angew. Chem., Int. Ed., 2013, 52, 988 CrossRef CAS PubMed; (h) D. R. Whang, K. Sakai and S. Y. Park, Angew. Chem., Int. Ed., 2013, 52, 11612 CrossRef CAS PubMed; (i) K. Mori, Y. Kubota and H. Yamashita, Chem.–Asian J., 2013, 8, 3207 CrossRef CAS PubMed; (j) H. Jiang, Y. Cheng, R. Wang, Y. Zhang and S. Yu, Chem. Commun., 2014, 50, 6164 RSC.
  6. (a) Z. Lu and T. P. Yoon, Angew. Chem., Int. Ed., 2012, 51, 10329 CrossRef CAS PubMed; (b) M. A. Ischay, M. S. Ament and T. P. Yoon, Chem. Sci., 2012, 3, 2807 RSC; (c) E. L. Tyson, E. P. Farney and T. P. Yoon, Org. Lett., 2012, 14, 1110 CrossRef CAS PubMed; (d) E. P. Farney and T. P. Yoon, Angew. Chem., Int. Ed., 2013, 53, 793 CrossRef PubMed; (e) M. A. Cismesia, M. A. Ischay and T. P. Yoon, Synthesis, 2013, 45, 2699 CrossRef CAS PubMed; (f) T. P. Yoon, ACS Catal., 2013, 3, 895 CrossRef CAS PubMed; (g) L. Ruiz Espelt, E. M. Wiensch and T. P. Yoon, J. Org. Chem., 2013, 78, 4107 CrossRef CAS PubMed; (h) J. Du, K. L. Skubi, D. M. Schultz and T. P. Yoon, Science, 2014, 344, 392 CrossRef CAS PubMed; (i) D. M. Schultz and T. P. Yoon, Science, 2014, 343, 1239176 CrossRef PubMed; (j) Z. Lu, J. D. Parrish and T. P. Yoon, Tetrahedron, 2014, 70, 4270 CrossRef CAS PubMed; (k) E. L. Tyson, Z. L. Niemeyer and T. P. Yoon, J. Org. Chem., 2014, 79, 1427 CrossRef CAS PubMed.
  7. (a) D. A. Nicewicz and D. W. C. MacMillan, Science, 2008, 322, 77 CrossRef CAS PubMed; (b) D. A. Nagib, M. E. Scott and D. W. C. MacMillan, J. Am. Chem. Soc., 2009, 131, 10875 CrossRef CAS PubMed; (c) H.-W. Shih, M. N. V. Wal, R. L. Grange and D. W. C. MacMillan, J. Am. Chem. Soc., 2010, 132, 13600 CrossRef CAS PubMed; (d) P. V. Pham, D. A. Nagib and D. W. C. MacMillan, Angew. Chem., 2011, 123, 6243 (Angew. Chem., Int. Ed., 2011, 50, 6119) CrossRef.
  8. (a) L. Furst, J. M. R. Narayanam and C. R. J. Stephenson, Angew. Chem., 2011, 123, 9829 (Angew. Chem., Int. Ed., 2011, 50, 9655) CrossRef; (b) J. D. Nguyen, J. W. Tucker, M. D. Konieczynska and C. R. J. Stephenson, J. Am. Chem. Soc., 2011, 133, 4160 CrossRef CAS PubMed; (c) C. Dai, J. M. R. Narayanam and C. R. J. Stephenson, Nat. Chem., 2011, 3, 140 CrossRef CAS PubMed; (d) J. D. Nguyen, E. M. D'Amato, J. M. R. Narayanam and C. R. J. Stephenson, Nat. Chem., 2012, 4, 854 CrossRef CAS PubMed; (e) C.-J. Wallentin, J. D. Nguyen, P. Finkbeiner and C. R. J. Stephenson, J. Am. Chem. Soc., 2012, 134, 8875 CrossRef CAS PubMed; (f) M. D. Konieczynska, C. Dai and C. R. J. Stephenson, Org. Biomol. Chem., 2012, 10, 4509 RSC; (g) J. W. Tucker, Y. Zhang, T. F. Jamison and C. R. J. Stephenson, Angew. Chem., Int. Ed., 2012, 51, 4144 CrossRef CAS PubMed; (h) D. B. Freeman, L. Furst, A. G. Condie and C. R. J. Stephenson, Org. Lett., 2012, 14, 94 CrossRef CAS PubMed; (i) J. D. Nguyen, B. Reiss, C. Dai and C. R. J. Stephenson, Chem. Commun., 2013, 49, 4352 RSC.
  9. (a) M.-H. Larraufie, R. Pellet, L. Fensterbank, J.-P. Goddard, E. Lacote, M. Malacria and C. Ollivier, Angew. Chem., 2011, 123, 4555 (Angew. Chem., Int. Ed., 2011, 50, 4463) CrossRef; (b) M. Rueping, S. Zhu and R. M. Koenigs, Chem. Commun., 2011, 47, 8679 RSC; (c) R. S. Andrews, J. J. Becker and M. R. Gagne, Org. Lett., 2011, 13, 2406 CrossRef CAS PubMed; (d) Y. Chen, A. S. Kamlet, J. B. Steinman and D. R. Liu, Nat. Chem., 2011, 3, 146 CrossRef CAS PubMed; (e) Y. N. Cheng, X. Y. Gu and P. X. Li, Org. Lett., 2013, 15, 2664 CrossRef CAS PubMed; (f) V. S. Thoi, N. Kornienko, C. G. Margarit, P. D. Yang and C. J. Chang, J. Am. Chem. Soc., 2013, 135, 14413 CrossRef CAS PubMed; (g) S. Lee, Y. You, K. Ohkubo, S. Fukuzumi and W. Nam, Chem. Sci., 2014, 5, 1463 RSC; (h) D. Cantillo, O. de Frutos, J. A. Rincon, C. Mateos and C. O. Kappe, Org. Lett., 2014, 16, 896 CrossRef CAS PubMed; (i) Y. Miyake, Y. Ashida, K. Nakajima and Y. Nishibayashi, Chem.–Eur. J., 2014, 20, 6210 CrossRef PubMed.
  10. Y. Su, L. Zhang and N. Jiao, Org. Lett., 2011, 13, 2168 CrossRef CAS PubMed.
  11. A. Itoh, T. Kodama, S. Inagaki and Y. Masaki, Org. Lett., 2001, 3, 2653 CrossRef CAS PubMed.
  12. (a) T. Lazarides, T. McCormick, P. Du, G. Luo, B. Lindley and R. Eisenberg, J. Am. Chem. Soc., 2009, 131, 9192 CrossRef CAS PubMed; (b) M. Neumann, S. Fuldner, B. Konig and K. Zeitler, Angew. Chem., 2011, 123, 981 (Angew. Chem., Int. Ed., 2011, 50, 951) CrossRef; (c) D. Ravelli and M. Fagnoni, ChemCatChem, 2012, 4, 169 CrossRef CAS; (d) D. A. Nicewicz and T. M. Nguyen, ACS Catal., 2014, 4, 355 CrossRef CAS; (e) D. P. Hari and B. Koenig, Chem. Commun., 2014, 50, 6688 RSC.
  13. (a) M. Watanabe, H. Koike, T. Ishiba, T. Okada, S. Seo and K. Hirai, Bioorg. Med. Chem., 1997, 5, 437 CrossRef CAS; (b) F. Ragaini, F. Ventriglia, M. Hagar, S. Fantauzzi and S. Cenini, Eur. J. Org. Chem., 2009, 13, 2185 CrossRef; (c) Z. Casar, Curr. Org. Chem., 2010, 14, 816 CrossRef CAS; (d) J. T. Zacharia, T. Tanaka and M. Hayashi, J. Org. Chem., 2010, 75, 7514 CrossRef CAS PubMed.
  14. (a) A. Endo and K. Hasumi, Nat. Prod. Rep., 1993, 10, 541 RSC; (b) E. S. Istvan and J. Deisenhofer, Science, 2001, 292, 1160 CrossRef CAS PubMed; (c) C. I. Carswell, G. L. Plosker and B. Jarvis, Drugs, 2002, 62, 2075 CrossRef CAS PubMed; (d) J. A. Tobert, Nat. Rev. Drug Discovery, 2003, 2, 517 CrossRef CAS PubMed; (e) J. Quirk, M. Thornton and P. Kirkpatrick, Nat. Rev. Drug Discovery, 2003, 2, 769 CrossRef CAS PubMed; (f) J. Kidd, Nat. Rev. Drug Discovery, 2006, 5, 813 CrossRef CAS PubMed; (g) A. Endo, Nat. Med., 2008, 14, 1050 CrossRef CAS PubMed; (h) M. H. Davidson and J. G. Robinson, Expert Opin. Pharmacother., 2006, 7, 1701 CrossRef CAS PubMed; (i) H. Soran and P. Durrington, Expert Opin. Pharmacother., 2008, 9, 2145 CrossRef CAS PubMed.
  15. D. Sterk, Z. Casar, M. Jukic and J. Kosmrlj, Tetrahedron, 2012, 68, 2155 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental details and the characterization data for all compounds. See DOI: 10.1039/c4ra09190f

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.